Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Grant or award Director acquired 8,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 16,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 16,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale Chief Executive Officer sold 72,995 shares at $9.46 ($690,365)
  8. 4 Planned sale EVP & Chief Technology Officer sold 2,711 shares at $10.05 ($27,251)
  9. 4 Open-market sale EVP & Chief Financial Officer sold 6,008 shares at $9.89 ($59,404)
  10. 4 Planned sale EVP & Chief Technology Officer sold 12,296 shares at $10.05 ($123,521)
  11. 4 Grant or award Chief Executive Officer acquired 175,000 shares (grant or award)
  12. 4 Grant or award EVP & Chief Financial Officer acquired 40,000 shares (grant or award)
  13. 4 Planned sale EVP & Chief Medical Officer sold 14,568 shares at $10.05 ($146,344)
  14. 4 Planned sale Director sold 27,750 shares at an average $11.07 ($307,259)
  15. 4 Planned sale Director sold 27,750 shares at an average $10.23 ($283,771)
  16. 4 Planned sale EVP & Chief Medical Officer sold 3,321 shares at $10.24 ($34,006)
  17. 4 Exercise or conversion EVP & Chief Medical Officer acquired 80,000 shares (option exercise)
  18. 4 Other disposition Director disposed of 6,405 shares (other)
  19. 4 Other disposition Director disposed of 3,500,000 shares (other)
  20. 4 Other disposition Director disposed of 5,377,590 shares (other)

Page 6 of 25 · 491 filings